文献速递临床试验与 GCP

加速康复外科方案下胰十二指肠切除术后肠内与肠外营养比较:多中心、开放标签随机对照试验的研究方案(ENE-PAN试验)

Enteral versus parental nutrition after pancreaticoduodenectomy under enhanced recovery after surgery protocol: study protocol for a multicenter, open-label randomized controlled trial (ENE-PAN trial).
PubMed 文献 · Trials · 2022-10-29

这是一项多中心、开放标签随机对照试验方案,计划于2022年7月启动,纳入320例开腹胰十二指肠切除术患者,按1:1随机分为肠内营养组与外周肠外营养组,主要终点为术后90天内感染性并发症发生率,旨在明确加速康复外科方案下肠内营养是否获益。

要点

  • 多中心、开放标签随机对照试验,计划纳入320例开腹胰十二指肠切除术患者,按1:1随机分组。
  • 肠内营养组术后第1天经术中置入的经皮导管给予200-300 ml/天,第2天增至400-600 ml/天。
  • 主要终点为术后90天内感染性并发症发生率,次要终点包括Clavien-Dindo≥3级并发症和临床相关术后胰瘘。

核心结论

  • 本研究旨在确定加速康复外科方案下胰十二指肠切除术后肠内营养是否获益,将根据结果采用肠内营养或外周肠外营养作为标准营养支持。

研究设计与样本

  • 多中心(六家医院)、开放标签、随机对照试验,计划于2022年7月启动。
  • 计划纳入320例开腹胰十二指肠切除术患者,按1:1比例随机分配至肠内营养组或外周肠外营养组。
  • 分层因素为医院、年龄(是否≥70岁)和术前诊断(是否为胰腺癌)。
  • 按意向治疗分析。

关键数值与推荐

  • 肠内营养组:术后第1天经术中置入的经皮导管开始肠内营养,200-300 ml/天;第2天增至400-600 ml/天;第3天起由外科医生决定。
  • 外周肠外营养组:术后给予外周肠外营养。
  • 两组均于术后第3天开始经口进食,当经口摄入达到营养需求(25-30 kcal/天)的60%时终止相应治疗。
  • 主要终点为术后90天内感染性并发症发生率;次要终点为所有并发症,包括Clavien-Dindo≥3级主要并发症和临床相关术后胰瘘。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Infectious complications are the main causes of morbidity after pancreaticoduodenectomy (PD). Early enteral nutrition (EN) is a reasonable form of nutritional support that aims to mitigate the occurrence and severity of infectious complications by maintaining gut immunity. However, it remains unclear whether EN is beneficial for patients who underwent PD and are under enhanced recovery after surgery (ERAS) protocol. METHODS: A multicenter (six hospitals), open-label, randomized controlled trial will be started in July 2022. A total of 320 patients undergoing open PD will be randomly assigned to an EN group or a peripheral parental nutrition (PPN) group in a 1:1 ratio. The stratification factors will be the hospital, age (≥ 70 or not), and preoperative diagnosis (pancreatic cancer or not). In the EN group, enteral nutrition will start on postoperative day (POD) 1 at 200-300 ml/day via the percutaneous tube placed operatively. The volume of the diet will be increased to 400-600 ml/day on POD 2 and depend on the surgeon's decision from POD 3. In the PPN group, PPN will be delivered after surgery. In both groups, oral feeding will start on POD 3. Each treatment will be finished when patients' oral food intake reaches 60% of the nutritional requirement (25-30 kcal/day). The primary endpoint will be the occurrence of postoperative infectious complications within 90 days of surgery. The secondary endpoints will be all complications, including major ones such as Clavien-Dindo grade 3 or more and clinically relevant postoperative pancreatic fistula. Data will be analyzed per the intention to treat. DISCUSSION: This will be the first, large, and well-designed RCT that aims to determine whether EN is beneficial for patients who underwent PD under the ERAS protocol. According to the results of this study, either EN or PPN would be adopted as the standard nutritional support for patients undergoing PD. TRIAL REGISTRATION: jRCT1030210691. Registered on March 23, 2022.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Takeda Y, Mise Y, Kishi Y, et al. Enteral versus parental nutrition after pancreaticoduodenectomy under enhanced recovery after surgery protocol: study protocol for a multicenter, open-label randomized controlled trial (ENE-PAN trial). Trials. 2022. PMID: 36309760. doi:10.1186/s13063-022-06856-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。